The brief
- Galaxy passed 16,000 US procedures by September 2026, up from 5,000 in March 2025.
- Galaxy II software (Aug 2026) adds dual-mode imaging: low-dose tomosynthesis or full cone-beam CT.
- First commercial case in Asia came in Hong Kong in Sep 2026. An FDA warning letter (Apr 2025) flagged quality lapses.
Technical approach
A single-use bronchoscope
Each case uses a fresh scope, so hospitals skip cleaning and the infection risk of reused scopes. It costs more per case.
Confirm the tool is in the nodule
Galaxy turns a short sweep of a standard C-arm X-ray into 3D slices, showing whether the needle actually sits in the lesion.
Magnetic tracking plus live X-ray overlay
A magnetic field tracks the scope tip against a map from the CT scan, and the target is drawn onto live X-ray to correct drift.
